Crossmark

Comparison of [99mTc]3PRGD2 Imaging and [18F]FDG PET/CT in Breast Cancer and Expression of Integrin αvβ3 in Breast Cancer Vascular Endothelial Cells

Crossref DOI link: https://doi.org/10.1007/s11307-018-1178-y

Published Online: 2018-03-01

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Zhenying

Fu, Fangmeng

Li, Fang

Zhu, Zhaohui

Yang, Yinghong

Chen, Xiangjin

Jia, Bing

Zheng, Shan

Huang, Chao

Miao, Weibing
Funding

Funding for this research was provided by:

The Fujian Provincial Natural Science Foundation of China (2015J01459)

The Fujian Provincial Medical Innovate Foundation of China (2015-CX-21)
License Information

Text and Data Mining valid from 2018-03-01
More Information

Article History

First Online: 1 March 2018

Compliance with Ethical Standards

: The written informed consents were obtained from all patients.

: The authors declare that they have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This prospective trial was approved by the ethics committee of the First Affiliated Hospital of Fujian Medical University, Fujian, China. This study has been registered online at NIHExternalRef removed(NCT 02742168).